Co-Pay Cards & the Stalling of Drug Rebate Growth Part II – The HIE ‘Test Case’
Summary and Investment Conclusion On net, drug manufacturers are using co-pay cards to reduce the higher out-of-pocket (OOP) costs faced by beneficiaries on the health insurance exchanges (HIEs) as compared…